1000mg (Ranolazine 1000mg)
Ranolazine Tablet, Extended Release
Product Images NDC 27241-126
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 27241-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
500mg (Ranolazine 500mg)
Each tablet of this medicine contains 500mg of Ranolazine, which is an extended-release tablet, and is packaged in a bottle of 60 tablets. The usual dosage for this medicine should be referred to from the package insert, and it should be stored between 20 to 25°C (68 to 77°F), and excursions permitted to 15 to 30°C (59 to 86°F). It is a warning to keep it out of reach from children and one should swallow tablets whole, without crushing, breaking, or chewing. The medicine is marketed by Ajanta Pharma USA Inc, located in Bridgewater, NJ and manufactured in India.*
Structure (Ranolazine Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
